The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Daklinza (daclatasvir)

What type of adverse reactions were reported when taking Daklinza?

The most common side effects observed when using Daklinza in combination with sofosbuvir were headache and fatigue (in 10% or more of patients).

The FDA has warned that a serious slowing of the heart rate (symptomatic bradycardia) can occur when Daklinza is coadministered with amiodarone  and sofosbuvir.

Last Updated: July 2015

FDA Approved Daklinza (Daclatasvir) for the Treatment of Patients with Chronic Hepatitis C Genotype 3. http://news.bms.com/press-release/fda-approves-daklinza-daclatasvir-treatment-patients-chronic-hepatitis-c-genotype-3, Bristol-Myers Squibb Company. Retrieved July 27, 2015.

Financial Help Info for Daklinza (daclatasvir) . http://www.daklinza.bmscustomerconnect.com/support, Bristol-Myers Squibb Company. Retrieved July 27, 2015.

Highlights of Prescribing Information - DAKLINZA. http://packageinserts.bms.com/pi/pi_daklinza.pdf, Bristol-Myers Squibb Company. Retrieved July 27, 2015.

Patient Support Connect. http://www.patientsupportconnect.bmscustomerconnect.com/, Bristol-Myers Squibb Company. Retrieved July 27, 2015.